Vitamin D Receptor–Macrophage–IL-23 Axis in Inflammatory Bowel Disease: Pathogenic Mechanisms and Therapeutic Hope
Alexandra Grigoraș, Larisa Ghemiș, Ancuta Goriuc, Alice Murariu, Naomi Fiterman, Nura Jdid, Teofil Blaga, Georgeta Liliana Foia · 2026
Read Vitamin D Receptor–Macrophage–IL-23 Axis in Inflammatory Bowel Disease: Pathogenic Mechanisms and Therapeutic Hope by Alexandra Grigoraș, Larisa Ghemiș, Ancuta Goriuc, Alice Murariu, Naomi Fiterman, Nura Jdid, Teofil Blaga, Georgeta Liliana Foia (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13257716.txt.
Description
Alexandra Grigoraș and co-authors review a vitamin D signaling chain in inflammatory bowel disease in a 2026 article. Interleukin-23, made mainly by gut macrophages, drives chronic intestinal inflammation in Crohn disease and ulcerative colitis. Vitamin D deficiency is common in these patients, and its receptor sits in the same macrophages.
Receptor signaling restrains the aggressive macrophage state and thereby cuts interleukin-23 output. Lower output softens the Th17 response that damages gut tissue. Evidence for each link is summarized from cell, animal, and patient work. Treatment ideas targeting the chain range from vitamin correction to receptor-focused drugs. Gastroenterologists gain a mechanistic bridge between a common deficiency and a proven drug target. Trials must still show that strengthening this axis changes disease course, not only blood markers.
Catalog record
| CREATOR | Alexandra Grigoraș, Larisa Ghemiș, Ancuta Goriuc, Alice Murariu, Naomi Fiterman, Nura Jdid, Teofil Blaga, Georgeta Liliana Foia |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |